2020年(nian)1月，四川锦江电子科(ke)技有限(xian)公司(si)自主研发的NAVABLATOR®一(yi)次性使用心脏射频消融导管、PROMAPPER®一次(ci)性使用(yong)固定弯型心(xin)脏电生理(li)标(biao)测导(dao)管及PROMAPPER®一次性(xing)使用可调弯型心(xin)脏电生理(li)标测导管(guan)获国家药品(pin)监督管(guan)理(li)局（NMPA）批准上(shang)市(shi)，注(zhu)册证号分别为国械注(zhu)准20203010014、国械注准20203070027、国械注(zhu)准20203070026。
新推出(chu)的系列导管(guan)在(zai)延续锦(jin)江(jiang)电(dian)(dian)(dian)(dian)(dian)子(zi)(zi)数十年心电(dian)(dian)(dian)(dian)(dian)信(xin)号(hao)处理(li)(li)技(ji)术的同时(shi)，充分吸收(shou)美国CARDIMA公司(si)二十年心脏(zang)(zang)(zang)电(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)导管(guan)的技(ji)术优势。 该系列导管(guan)与锦(jin)江(jiang)电(dian)(dian)(dian)(dian)(dian)子(zi)(zi)的心脏(zang)(zang)(zang)三(san)维标测(ce)系统、多道生(sheng)(sheng)理(li)(li)记录(lu)仪、射(she)频消融仪配套为临床提(ti)供完(wan)整的解决方案，进一步(bu)完(wan)善了锦(jin)江(jiang)电(dian)(dian)(dian)(dian)(dian)子(zi)(zi)在(zai)心脏(zang)(zang)(zang)电(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)领域的产(chan)品布局(ju)。
